Juedes M J, Bulger W H, Kupfer D
Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545.
Drug Metab Dispos. 1987 Nov-Dec;15(6):786-93.
Chlorotrianisene is a therapeutic estrogen and contaminant of the pesticide methoxychlor. Incubation of [3H]chlorotrianisene with rat liver microsomes, supplemented with NADPH, yielded covalent binding of radiolabeled metabolite(s) to microsomal components. This binding was dramatically stimulated when microsomes from methylcholanthrene-treated rats were used. However, microsomes from phenobarbital-treated animals did not enhance binding. Analysis of solubilized microsomes by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed radiolabeled bands in the 45- to 66-kDa range. Furthermore, these bands were sensitive to protease degradation, indicating that the recipient macromolecules were proteins and possibly cytochrome P-450(s). Selective inhibition of binding to microsomes prepared from control, phenobarbital-, and methylcholanthrene-treated rats by inhibitors of monooxygenase activity [beta-diethylaminoethyl diphenylpropylacetate (SKF-525A) and metyrapone], by alternate substrates (ethylmorphine and benzo[a]pyrene), and by oxygen exclusion indicated that the binding was dependent upon monooxygenase activity and that a specific P-450 may be involved. Compounds containing free sulfhydryls markedly inhibited covalent binding, suggesting that the reactive intermediate is an epoxide or a free radical. The epoxide hydratase inhibitor (1,1,1-trichloropropane oxide) failed to enhance covalent binding, suggesting that an epoxide of chlorotrianisene was not the reactive intermediate. By contrast, free radical scavengers (propyl gallate, N,N'-diphenylenediamine, and ascorbic acid) markedly inhibited covalent binding, indicating that binding was mediated via a free radical. Since both methylcholanthrene and phenobarbital did not enhance demethylation of chlorotrianisene and methylcholanthrene increased covalent binding, it appears that demethylation products are not involved in covalent binding or that demethylation is not the rate-limiting step. A possible pathway for the metabolism and covalent binding of chlorotrianisene is presented.
氯烯雌醚是一种治疗用雌激素,也是杀虫剂甲氧滴滴涕的污染物。将[3H]氯烯雌醚与补充了NADPH的大鼠肝微粒体一起温育,会使放射性标记的代谢物与微粒体成分发生共价结合。当使用来自经甲基胆蒽处理的大鼠的微粒体时,这种结合会显著增强。然而,来自经苯巴比妥处理的动物的微粒体并不会增强结合。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳对溶解的微粒体进行分析,发现在45至66 kDa范围内有放射性标记条带。此外,这些条带对蛋白酶降解敏感,这表明受体大分子是蛋白质,可能是细胞色素P-450。用单加氧酶活性抑制剂[β-二乙氨基乙基二苯基丙基乙酸酯(SKF-525A)和甲吡酮]、替代底物(乙基吗啡和苯并[a]芘)以及通过排除氧气对来自对照、苯巴比妥处理和甲基胆蒽处理大鼠制备的微粒体的结合进行选择性抑制,表明这种结合依赖于单加氧酶活性,并且可能涉及一种特定的P-450。含有游离巯基的化合物显著抑制共价结合,这表明反应性中间体是一种环氧化物或自由基。环氧化物水合酶抑制剂(1,1,1-三氯环氧丙烷)未能增强共价结合,这表明氯烯雌醚的环氧化物不是反应性中间体。相比之下,自由基清除剂(没食子酸丙酯、N,N'-二苯二胺和抗坏血酸)显著抑制共价结合,表明结合是通过自由基介导的。由于甲基胆蒽和苯巴比妥都没有增强氯烯雌醚的去甲基化,并且甲基胆蒽增加了共价结合,似乎去甲基化产物不参与共价结合,或者去甲基化不是限速步骤。本文提出了氯烯雌醚代谢和共价结合的一种可能途径。